
AANMA has enjoyed a long history of bipartisan support from Congress to change laws affecting schoolchildren with asthma and anaphylaxis. We’ve worked with federal agencies such as FDA, EPA, CDC, NHLBI and NIAID to ensure evidence-based, cost-effective and patient-centered care. This collaborative effort means that today, it is possible to improve patient quality of life, prevent asthma and anaphylaxis deaths and suffering while reducing healthcare costs. Read the rest of this entry »









RSS Feed